USPH vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

USPH

53.9
AI Score
VS
USPH Wins

ASTH

45.3
AI Score

Investment Advisor Scores

USPH

54score
Recommendation
HOLD

ASTH

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric USPH ASTH Winner
Revenue 412.34M 1.94B ASTH
Net Income 14.94M 34.17M ASTH
Net Margin 3.6% 1.8% USPH
Operating Income 34.43M 62.85M ASTH
ROE 3.3% 4.1% ASTH
ROA 1.2% 1.5% ASTH
Total Assets 1.25B 2.28B ASTH
Cash 24.89M 400.79M ASTH
Debt/Equity 0.48 1.06 USPH
Current Ratio 1.27 1.23 USPH

Relative Price Performance (Last 90 Days)

USPH 1M: -3.9% · 3M: +19.7% ASTH 1M: +6.1% · 3M: -4.7%

Current Technical Phase

USPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 54

RSI (14): 53.7 · Price: $78.72

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $37.98

Fundamentals Snapshot

Metric USPH ASTH
Market Cap
Forward P/E 23.3 10.7
Trailing P/E 457.1 46.4
Revenue (TTM)
Revenue Growth 0.1% 0.5%
Gross Margin 0.2% 0.1%
Operating Margin 0.1% 0.0%
EPS 0.17 0.82
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, USPH is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.